European Companies Search Engine

26 EU fundings (€10.2M): Targeting Tau-induced cognitive decline with antisense oligonucleotides to synaptogyrin-3 … BdlYear 2020 EU Research and Innovation programme "Horizon"

Text

Crossroads Bank for Enterprises (KBO) 0456.343.923

15/10/2020 EU funding (€1,499,327): Understanding organelle communication through contact sites in plant stress responses
04/03/2020 EU funding (€1,999,963): Dissecting the molecular mechanisms that execute developmental programmed cell death in plants
01/01/2020 EU funding (€15.5M): Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
26/11/2020 EU funding (€150,000): AI-driven enhancer design for gene therapy
07/05/2020 EU funding (€150,000): CIRCULATING TUMOR DNA AS AN EPIGENETIC BIOMARKER FOR TUMOR RESPONSE
11/09/2020 EU funding (€150,000): Generating superior industrial yeasts through modulation of Crabtree repression
09/12/2020 EU funding (€150,000): Targeting Tau-induced cognitive decline with antisense oligonucleotides to synaptogyrin-3
01/04/2020 EU funding (€166,320): Study of phenol-like compound, a newly discovered class of plant specialized metabolites.
25/03/2020 EU funding (€178,320): Exploring the non-genetic (i.e. ePIgenetic) mechanisms that contribute to therapy Escape in melanoma
14/05/2020 EU funding (€178,320): Functional Organization of Immunity by Lymphoid Stromal Cells
13/01/2020 EU funding (€178,320): In vivo Directed Evolution of Ribulose-1,5-Bisphosphate Carboxylase/Oxygenase in Saccharomyces cerevisiae Using an Orthogonal DNA Replication System
04/03/2020 EU funding (€178,320): The role of TETRASPANINS in plant cell division orientation
27/02/2020 EU funding (€178,320): Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity
07/04/2020 EU funding (€178,320): Understanding resistance to immune checkpoint inhibitors by mapping the tumor-host ecosystem at single-cell resolution
04/09/2020 EU funding (€2,856,013): Multidisciplinary Training of Young Researchers in Novel Implantable Bio-inspired sensors
13/03/2020 EU funding (€266,426): Microbiota modulation through horizontal gene transfer.
01/02/2020 EU funding (€3,363,591): System omics to unravel the gut-kidney axis in Chronic Kidney Disease.
21/08/2020 EU funding (€3,917,904): Computational Proteomics Training European Innovative Network
01/01/2020 EU funding (€6,000,000): Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe
01/01/2020 EU funding (€6,000,000): MiCrovasculaR rarefaction in vascUlar Cognitive Impairement and heArt faiLure
31/05/2020 EU funding (€6,715,625): HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS
01/01/2020 EU funding (€8,168,495): Novel Strategies for Cell-based Neural Reconstruction
12/02/2020 EU funding (€8,646,254): Evaluation of ratioNally Designed Influenza vaccines
14/07/2020 EU funding (€899,741): Excellence Hub on Phase Transitions in Aging and Age-Related Disorders
01/02/2020 EU funding (€9,800,000): Connect and align ELIXIR Nodes to deliver sustainable FAIR life-science data management services

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW, Ghent, Belgium.

Creative Commons License The visualizations for "26 EU fundings (€10.2M): Targeting Tau-induced cognitive decline with antisense oligonucleotides to synaptogyrin-3 …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.